Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04888637 · ClinicalTrials.gov registry record
Pediatric Language and Memory Mapping in Refractory Epilepsy Using Magnetoencephalography
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 10
- Enrollment target
NCT04888637: Completed study, sponsored by University of Arkansas.
NCT04888637 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04888637 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is a pilot research study where language and working memory tasks will be used to study brain activities from children with epilepsy. Specifically for language assessment, a well-known MEG language protocol will be used and novel signal processing techniques will be applied. A widely utilized paradigm will be used to study memory function and adapt signal-processing techniques from previous literature for the processing and analysis of MEG signals collected during memory task. No treatment/intervention will be performed or evaluated in this pilot research study.
Primary Outcome
This is not a treatment/intervention study. Pilot study was to record brain activity utilizing a noninvasive MEG system during resting state, receptive language and working memory tasks.
Interventions
- DIAGNOSTIC_TEST Baseline MEG Test
- BEHAVIORAL Receptive Language Task
- BEHAVIORAL Memory Task
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2022-07-22 |
What the finished NCT04888637 record still lists
NCT04888637 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Baseline MEG Test is the first listed.
NCT04888637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04888637 about?
NCT04888637 is a clinical study titled "Pediatric Language and Memory Mapping in Refractory Epilepsy Using Magnetoencephalography". This is a pilot research study where language and working memory tasks will be used to study brain activities from children with epilepsy. Specifically for language assessment, a well-known MEG language protocol will be used and novel signal processing techniques will be applied. A widely utilized p...
What is the current status of trial NCT04888637?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2021-07-14. Estimated completion is 2022-07-22.
What interventions are being tested in trial NCT04888637?
The interventions under investigation include: Baseline MEG Test (DIAGNOSTIC_TEST), Receptive Language Task (BEHAVIORAL), Memory Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT04888637?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI